Pulse Biosciences Statistics
Total Valuation
PLSE has a market cap or net worth of $397.07 million. The enterprise value is $361.85 million.
| Market Cap | 397.07M |
| Enterprise Value | 361.85M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PLSE has 55.23 million shares outstanding. The number of shares has increased by 41.56% in one year.
| Shares Outstanding | 55.23M |
| Shares Change (YoY) | +41.56% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 70.38% |
| Owned by Institutions (%) | 8.15% |
| Float | 16.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.76, with a Debt / Equity ratio of 0.21.
| Current Ratio | 6.76 |
| Quick Ratio | n/a |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 31.95 |
Financial Efficiency
Return on equity (ROE) is -115.40% and return on invested capital (ROIC) is -81.44%.
| Return on Equity (ROE) | -115.40% |
| Return on Assets (ROA) | -62.50% |
| Return on Capital (ROIC) | -81.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$691,967 |
| Employee Count | 61 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.61% in the last 52 weeks. The beta is 1.69, so PLSE's price volatility has been higher than the market average.
| Beta (1Y) | 1.69 |
| 52-Week Price Change | +24.61% |
| 50-Day Moving Average | 8.85 |
| 200-Day Moving Average | 7.44 |
| Relative Strength Index (RSI) | 35.42 |
| Average Volume (30 Days) | 173,887 |
Short Selling Information
The latest short interest is 2.63 million, so 4.76% of the outstanding shares have been sold short.
| Short Interest | 2.63M |
| Short Previous Month | 2.50M |
| Short % of Shares Out | 4.76% |
| Short % of Float | 16.10% |
| Short Ratio (days to cover) | 17.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.57M |
| Pretax Income | -42.21M |
| Net Income | -42.21M |
| EBITDA | -42.37M |
| EBIT | -43.57M |
| Earnings Per Share (EPS) | -$0.88 |
Balance Sheet
The company has $44.37 million in cash and $9.14 million in debt, giving a net cash position of $35.22 million or $0.64 per share.
| Cash & Cash Equivalents | 44.37M |
| Total Debt | 9.14M |
| Net Cash | 35.22M |
| Net Cash Per Share | $0.64 |
| Equity / Book Value | 44.36M |
| Book Value Per Share | 0.80 |
| Working Capital | 38.62M |
Cash Flow
In the last 12 months, operating cash flow was -$33.04 million and capital expenditures -$121,000, giving a free cash flow of -$33.16 million.
| Operating Cash Flow | -33.04M |
| Capital Expenditures | -121,000 |
| Free Cash Flow | -33.16M |
| FCF Per Share | -$0.69 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PLSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.56% |
| Shareholder Yield | -41.56% |
| Earnings Yield | -10.63% |
| FCF Yield | -8.35% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |